Quick Takeaways
- FMR LLC has 16 issuer positions tracked on this page.
- Estimated disclosed ownership value: $584,741,476.
- Recent insider filing activity is available below.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of FMR LLC
- Location
- Boston, MA
- Summary
- The estimated value of insider holdings of FMR LLC is at least $584,741,476 dollars as of 10 Mar 2026. FMR LLC is the Other* of Flywire Corp and owns shares of Flywire Corp (FLYW) stock worth about $135.06M. FMR LLC is the Other* of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $126.7M. FMR LLC is the Other* of Toast, Inc. and owns shares of Toast, Inc. (TOST) stock worth about $113.42M. FMR LLC is the Other* of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $67.38M. FMR LLC is the Other*, 10%+ Owner of Structure Therapeutics Inc. and owns shares of Structure Therapeutics Inc. (GPCR) stock worth about $54.57M. FMR LLC is the Other*, 10%+ Owner of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $48.07M. FMR LLC is the Other* of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $14.77M. FMR LLC is the Other* of Caribou Biosciences, Inc. and owns shares of Caribou Biosciences, Inc. (CRBU) stock worth about $9.84M. FMR LLC is the Other*, 10%+ Owner of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $7.49M. FMR LLC is the Other* of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. stock worth about $5.71M. FMR LLC is the Other* of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.58M. FMR LLC is the Other*, 10%+ Owner of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $122.8K. FMR LLC is the Other* of Fidelity Private Credit Fund and owns shares of Fidelity Private Credit Fund stock worth about $20.3K.
- Signature
- /s/ Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow FMR LLC and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Flywire Corp ($135,059,447).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of FMR LLC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FLYW | Flywire Corp | Other* | $135,059,447 | 28 May 2021 | ||
| PRME | Prime Medicine, Inc. | Other* | $126,699,612 | 24 Oct 2022 | ||
| TOST | Toast, Inc. | Other* | $113,421,254 | 09 Nov 2021 | ||
| NMRA | Neumora Therapeutics, Inc. | Other* | $67,379,749 | 19 Sep 2023 | ||
| GPCR | Structure Therapeutics Inc. | Other*, 10%+ Owner | $54,574,954 | -$4,061,544 | -6.9% | 15 Jan 2026 |
| BEAM | Beam Therapeutics Inc. | Other*, 10%+ Owner | $48,071,330 | -$1,003,913 | -2% | 27 Oct 2025 |
| BCAX | Bicara Therapeutics Inc. | Other* | $14,770,801 | 16 Sep 2024 | ||
| CRBU | Caribou Biosciences, Inc. | Other* | $9,836,921 | 27 Jul 2021 | ||
| SANA | Sana Biotechnology, Inc. | Other*, 10%+ Owner | $7,493,594 | 08 Jan 2025 | ||
| VERV | Verve Therapeutics, Inc. | Other* | $5,707,290 | 26 Jul 2022 | ||
| XLO | Xilio Therapeutics, Inc. | Other* | $1,583,366 | 26 Oct 2021 | ||
| RLYB | Rallybio Corp | Other*, 10%+ Owner | $122,842 | 04 Mar 2026 | ||
| Fidelity Private Credit Fund | Other* | $20,316 | 29 Jan 2024 | |||
| MTSR | Metsera, Inc. | Other*, 10%+ Owner | $0 | -$11,817 | -100% | 13 Nov 2025 |
| Fidelity Multi-Strategy Credit Fund | Other*, 10%+ Owner | 19 May 2023 | ||||
| TSBX | Turnstone Biologics Corp. | Other* | 09 Jan 2024 |
Insider Transactions Reported by FMR LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.